CG
CELG

CFO4Life Group’s Celgene Corp CELG Stock Holding History

CFO4Life Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,088
Closed -$365K – 137
2018
Q1 		$365K Sell
4,088
-46
-1% -$4.42K 0.31% 55
2017
Q4 		$431K Sell
4,134
-176
-4% -$19.9K 0.34% 50
2017
Q3 		$628K Sell
4,310
-16
-0.4% -$2.18K 0.51% 30
2017
Q2 		$562K Buy
4,326
+222
+5% +$27.2K 0.52% 32
2017
Q1 		$511K Buy
+4,104
New +$491K 0.46% 38

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFO4Life Group's CELG Position: Q2 2018 in Review

CFO4Life Group sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 4,088 shares — an estimated $365K sold.

CFO4Life Group first reported a position in CELG in Q1 2017 and held it in 5 quarters. The position peaked at $628K in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • CFO4Life Group reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • CFO4Life Group sold 4,088 Celgene Corp shares in Q2 2018, an estimated $365K.
  • CFO4Life Group first reported a position in Celgene Corp in Q1 2017 and held it in 5 quarters.
  • CFO4Life Group's Celgene Corp position peaked at $628K in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on CFO4Life Group's 13F filing for Q2 2018, filed 1 Aug 2018.